A Retrospective Study of the Prognostic Patterns in Colorectal Cancer Patients.
| Autor: | Patil JD; Obstetrics and Gynaecology, University Hospitals of Leicester NHS Trust, Leicester, GBR., Mohamed YM; Emergency Medicine, Salmaniya Medical Complex, Manama, BHR., AlMarzooq R; General Surgery, Al Kindi Hospital, Manama, BHR. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 May 04; Vol. 15 (5), pp. e38522. Date of Electronic Publication: 2023 May 04 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.38522 |
| Abstrakt: | Introduction Colorectal cancer (CRC) management has advanced globally, leading to a steady decline in mortality rates. However, recent studies have shown that the prognosis of CRC varies based on the anatomical site of the primary tumor, histopathological grading, and type of mutation. With an increase in the incidence of CRC globally and in Bahrain, there is a need for a recent descriptive study to improve overall management. This study aims to investigate the anatomical, histopathological, and molecular prognostic factors in CRC patients presenting to the Salmaniya Medical Complex (SMC). Methods The study was conducted retrospectively using ISEHA electronic database over two years (January 2019 to December 2020). A total of 101 patients with primary CRC registered in the General Surgery Department were included in this study. The sample size was further stratified and analyzed using descriptive statistics based on the available data of measured outcomes. Results Anatomical data showed that 65% of CRC patients had a tumor on the left side of the colon, 27.7% on the right side, and 7% in the transverse colon. Overall, 16.8% of all patients had rectal involvement. Histopathological data showed that 86% of the patients had a low-grade CRC adenocarcinoma. The most diagnosed tumor stage was pT3N0M0 (22.8%). In addition, there were ten metastatic cases (10 to the liver, of which three had concomitant lung involvement and two had concurrent brain metastases). The average tumor diameter was 46.2 mm, where 63% ranged between 30 mm to 69 mm. Most mutations involved the TP53 (27.7%) and the KRAS (29%) genes. Conclusion The study found that majority of CRC patients at SMC in Bahrain had relatively good overall anatomical, tumor staging and grading prognostic factors but somewhat poorer molecular prognostics. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Patil et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|